Clinical Trial Update: Perhexiline Therapy in Heart Failure With Preserved Ejection Fraction Syndrome [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial assesses perhexiline therapy in heart failure with preserved ejection fraction (diastolic heart failure).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Heart Failure
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Perhexiline (perhexiline)

Snippet

Sponsor: University of Aberdeen | Conditions: Diastolic Heart Failure | Phase 2 | Status: COMPLETED